|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.97 AUD | -1.17% |
|
-0.08% | +2.23% |
| 01-13 | Monash IVF Group Remains 'Potentially Attractive' Following Withdrawn Deal, Jefferies Says | MT |
| 12-24 | Monash IVF Group Says Consortium Withdraws Takeover Proposal; Shares Fall 14% | MT |
| Fiscal Period: July | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.68 | 11.16 | 5.06 | 2.97 | 3.5 | |||||
Return on Total Capital | 4.37 | 12.65 | 5.43 | 3.17 | 3.74 | |||||
Return On Equity % | 6.24 | 7.24 | 8.13 | 5.59 | 3.95 | |||||
Return on Common Equity | 6.56 | -1.23 | 8.15 | 5.63 | 3.96 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 45.45 | 63.78 | 80.45 | 64.86 | 67.74 | |||||
SG&A Margin | 18.35 | 7.4 | 13.35 | 20.93 | 23.36 | |||||
EBITDA Margin % | 40.39 | 61.13 | 68.51 | 45.64 | 46.59 | |||||
EBITA Margin % | 26.94 | 55.96 | 66.28 | 42.07 | 42.99 | |||||
EBIT Margin % | 26.72 | 55.84 | 65.89 | 41.86 | 42.74 | |||||
Income From Continuing Operations Margin % | 19.75 | 17.72 | 58.35 | 43.26 | 25.71 | |||||
Net Income Margin % | 16.84 | -0.47 | 57.68 | 43.49 | 25.76 | |||||
Net Avail. For Common Margin % | 16.84 | -2.77 | 58.45 | 43.49 | 25.76 | |||||
Normalized Net Income Margin | 15 | 18.1 | 40.32 | 24.4 | 24.08 | |||||
Levered Free Cash Flow Margin | 23.44 | 31.59 | 20.45 | 16.54 | 29.63 | |||||
Unlevered Free Cash Flow Margin | 24.69 | 32.42 | 21.35 | 18.54 | 32.24 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.22 | 0.32 | 0.12 | 0.11 | 0.13 | |||||
Fixed Assets Turnover | 0.67 | 2.09 | 3.23 | 1.93 | 1.86 | |||||
Receivables Turnover (Average Receivables) | 17.66 | 32.74 | 6.36 | 3.35 | 3.36 | |||||
Inventory Turnover (Average Inventory) | 7.34 | 10.87 | 4.23 | 5.48 | 5.56 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.44 | 3.52 | 4.58 | 3.31 | 1.33 | |||||
Quick Ratio | 2.1 | 2.87 | 3.88 | 2.68 | 1.14 | |||||
Operating Cash Flow to Current Liabilities | 0.94 | 2.96 | 2.06 | 1.23 | 0.28 | |||||
Days Sales Outstanding (Average Receivables) | 20.67 | 11.15 | 57.41 | 109.32 | 108.75 | |||||
Days Outstanding Inventory (Average Inventory) | 49.72 | 33.57 | 86.23 | 66.75 | 65.66 | |||||
Average Days Payable Outstanding | 50.36 | 35.41 | 147.35 | 104.07 | 121.34 | |||||
Cash Conversion Cycle (Average Days) | 20.03 | 9.31 | -3.71 | 72.01 | 53.06 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 22.78 | 6.48 | 5 | 8.51 | 10.73 | |||||
Total Debt / Total Capital | 18.55 | 6.08 | 4.76 | 7.84 | 9.69 | |||||
LT Debt/Equity | 16.7 | 4.03 | 2.34 | 6.71 | 1.13 | |||||
Long-Term Debt / Total Capital | 13.6 | 3.79 | 2.22 | 6.18 | 1.02 | |||||
Total Liabilities / Total Assets | 31.27 | 14.46 | 10.84 | 13.45 | 15.84 | |||||
EBIT / Interest Expense | 12.16 | 41.52 | 38.99 | 13.11 | 9.97 | |||||
EBITDA / Interest Expense | 19.02 | 45.79 | 41.02 | 14.7 | 11.14 | |||||
(EBITDA - Capex) / Interest Expense | 13.93 | 40.93 | 32.26 | 9.95 | 9.11 | |||||
Total Debt / EBITDA | 1.73 | 0.32 | 0.53 | 1.42 | 1.5 | |||||
Net Debt / EBITDA | 0.24 | -0.31 | -1.07 | 0.04 | -0.21 | |||||
Total Debt / (EBITDA - Capex) | 2.36 | 0.36 | 0.67 | 2.1 | 1.83 | |||||
Net Debt / (EBITDA - Capex) | 0.33 | -0.35 | -1.37 | 0.06 | -0.25 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 18.32 | 119.09 | -59.83 | -4.38 | 23.27 | |||||
Gross Profit, 1 Yr. Growth % | 107.83 | 193.49 | -51.21 | -20.24 | 28.74 | |||||
EBITDA, 1 Yr. Growth % | 102.43 | 200.49 | -56.79 | -34.58 | 25.85 | |||||
EBITA, 1 Yr. Growth % | -318.44 | 370.28 | -54.77 | -37.56 | 25.95 | |||||
EBIT, 1 Yr. Growth % | -312.91 | 374.27 | -54.92 | -37.7 | 25.88 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -63.36 | 92.76 | 41.88 | -29 | -26.73 | |||||
Net Income, 1 Yr. Growth % | -71.33 | -104.74 | -5.44K | -27.78 | -26.98 | |||||
Normalized Net Income, 1 Yr. Growth % | -72.61 | 183.4 | -3.64 | -40.48 | 21.67 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -71.51 | -124.6 | -933.52 | -28.68 | -27.35 | |||||
Accounts Receivable, 1 Yr. Growth % | 82.19 | -45.1 | -10.61 | 43.32 | -13.1 | |||||
Inventory, 1 Yr. Growth % | 11.27 | -54.14 | 32.88 | 32.96 | -4.41 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -4.05 | -87.68 | 54.35 | 63.62 | 6.34 | |||||
Total Assets, 1 Yr. Growth % | 3.99 | 31.87 | 0.94 | 6.13 | 7.54 | |||||
Tangible Book Value, 1 Yr. Growth % | -3.94 | 110.14 | 1.98 | 2.9 | 4.73 | |||||
Common Equity, 1 Yr. Growth % | -3.45 | 106.39 | 3.24 | 3.06 | 4.63 | |||||
Cash From Operations, 1 Yr. Growth % | 50.6 | 131.69 | -35.13 | -44.5 | -23.5 | |||||
Capital Expenditures, 1 Yr. Growth % | -18.61 | 0.05 | -2.39 | -2.09 | -29.38 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 750.1 | 165.47 | -75.59 | -18.86 | 120.88 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 517.76 | 157.13 | -75.1 | -13.06 | 114.46 | |||||
Dividend Per Share, 1 Yr. Growth % | 3.33 | 16.13 | 20.83 | 9.2 | 8.42 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -0.09 | 42.39 | -2.85 | -37.98 | 8.57 | |||||
Gross Profit, 2 Yr. CAGR % | 6.77 | 123.54 | 26.28 | -38.62 | 1.34 | |||||
EBITDA, 2 Yr. CAGR % | 11.34 | 129.12 | 20.44 | -47.49 | -9.26 | |||||
EBITA, 2 Yr. CAGR % | 8.82 | 178.86 | 54.9 | -47.56 | -11.32 | |||||
EBIT, 2 Yr. CAGR % | 8.79 | 176.12 | 55.28 | -47.63 | -11.45 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -5.56 | -24.96 | 65.37 | 0.37 | -27.87 | |||||
Net Income, 2 Yr. CAGR % | 4.97 | -88.35 | 59.01 | 520.84 | -27.39 | |||||
Normalized Net Income, 2 Yr. CAGR % | 15.03 | -24.76 | 64.94 | -25.27 | -14.9 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 4.69 | -74.54 | 43.2 | 143.82 | -28.12 | |||||
Accounts Receivable, 2 Yr. CAGR % | 20.5 | 0.01 | -29.95 | 80.41 | 11.6 | |||||
Inventory, 2 Yr. CAGR % | 2.66 | -28.56 | -29.49 | 32.9 | 12.74 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -6.12 | -65.62 | -56.39 | 58.91 | 31.91 | |||||
Total Assets, 2 Yr. CAGR % | 12.95 | 17.1 | 14.3 | 3.5 | 6.83 | |||||
Tangible Book Value, 2 Yr. CAGR % | 7.81 | 42.07 | 46.39 | 2.44 | 3.81 | |||||
Common Equity, 2 Yr. CAGR % | 7.81 | 41.16 | 45.97 | 3.15 | 3.85 | |||||
Cash From Operations, 2 Yr. CAGR % | 18.59 | 86.8 | 22.59 | -40 | -34.84 | |||||
Capital Expenditures, 2 Yr. CAGR % | -3.47 | -9.76 | -1.18 | -2.24 | -16.84 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 83.67 | 343.03 | -13.96 | -56.51 | 33.84 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 76.37 | 272.84 | -14.6 | -54.49 | 36.51 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.39 | 9.54 | 18.46 | 14.87 | 8.81 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.53 | 19.59 | -4.41 | -3.31 | -22.02 | |||||
Gross Profit, 3 Yr. CAGR % | 1.58 | 39.95 | 39.51 | 7.18 | -21.43 | |||||
EBITDA, 3 Yr. CAGR % | -2.31 | 47.59 | 36.34 | -2.55 | -29.73 | |||||
EBITA, 3 Yr. CAGR % | -2.69 | 61.54 | 58.31 | 13.41 | -29.77 | |||||
EBIT, 3 Yr. CAGR % | -2.84 | 61.82 | 57.08 | 13.62 | -29.85 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -4.95 | 11.08 | -7.21 | 24.76 | -9.62 | |||||
Net Income, 3 Yr. CAGR % | 0.79 | -62.63 | -10.17 | 22.22 | 204.18 | |||||
Normalized Net Income, 3 Yr. CAGR % | -9.2 | 39.84 | -18.39 | 16.39 | -12.09 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -3.77 | -37.06 | -18.56 | 13.51 | 62.71 | |||||
Accounts Receivable, 3 Yr. CAGR % | 7.84 | -7.28 | -3.67 | 21.34 | 41.42 | |||||
Inventory, 3 Yr. CAGR % | 10.84 | -21.52 | -17.91 | -12.9 | 19.08 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.92 | -52.29 | -43.28 | -32.24 | 39 | |||||
Total Assets, 3 Yr. CAGR % | 12.29 | 18.94 | 10.76 | 11.51 | 4.83 | |||||
Tangible Book Value, 3 Yr. CAGR % | 6.34 | 34.67 | 27.21 | 30.16 | 3.2 | |||||
Common Equity, 3 Yr. CAGR % | 6.73 | 33.87 | 27.18 | 29.98 | 3.64 | |||||
Cash From Operations, 3 Yr. CAGR % | 0.47 | 48.25 | 31.3 | -5.87 | -34.94 | |||||
Capital Expenditures, 3 Yr. CAGR % | 6.77 | -2.31 | -7.37 | -1.48 | -12.28 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -9.64 | 98.23 | 76.23 | -16.91 | -25.26 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -8.26 | 91.29 | 57.98 | -15.35 | -23.71 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.45 | 7.47 | 13.19 | 15.29 | 12.68 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 16.33 | 20.4 | -1.15 | -6.73 | 0.61 | |||||
Gross Profit, 5 Yr. CAGR % | 14.83 | 26.12 | 6.49 | 2.83 | 21.97 | |||||
EBITDA, 5 Yr. CAGR % | 21.54 | 31.08 | 3.14 | -0.2 | 15.27 | |||||
EBITA, 5 Yr. CAGR % | 33.39 | 35.55 | 10.85 | 5.51 | 24.89 | |||||
EBIT, 5 Yr. CAGR % | 33.62 | 35.63 | 10.8 | 5.56 | 24.31 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 19.87 | 4.7 | 13.37 | 6.67 | -16.1 | |||||
Net Income, 5 Yr. CAGR % | 12.83 | -47.79 | 20.95 | 15 | -17.5 | |||||
Normalized Net Income, 5 Yr. CAGR % | 8.53 | 13.54 | 8.23 | 8.76 | -17.46 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.69 | -28.63 | 11.06 | 8.19 | -22.52 | |||||
Accounts Receivable, 5 Yr. CAGR % | 12.92 | 2.93 | -9.25 | 21 | 23.12 | |||||
Inventory, 5 Yr. CAGR % | 9.94 | -6.15 | -7.51 | -6.98 | -6.81 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.73 | -30.43 | -24.47 | -22.8 | -20.51 | |||||
Total Assets, 5 Yr. CAGR % | 11.54 | 15.8 | 13.09 | 12.09 | 9.17 | |||||
Tangible Book Value, 5 Yr. CAGR % | 5.86 | 21.08 | 20.84 | 20.71 | 17.28 | |||||
Common Equity, 5 Yr. CAGR % | 6.14 | 21 | 20.97 | 20.61 | 17.28 | |||||
Cash From Operations, 5 Yr. CAGR % | 33.85 | 24.46 | 8.79 | 3.24 | -0.79 | |||||
Capital Expenditures, 5 Yr. CAGR % | 14.83 | 13.56 | 3.52 | -2.28 | -11.28 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 36.89 | 33.36 | -13.83 | 10.97 | 56.42 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 37.77 | 33.77 | -13.2 | 10.55 | 47.7 | |||||
Dividend Per Share, 5 Yr. CAGR % | 3.58 | 5.92 | 9.21 | 10.37 | 11.41 |
- Stock Market
- Equities
- SOL Stock
- Financials WHSP Holdings Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















